The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
Around 40% of workers admitted to working despite being too sick for the office, a survey has revealed.
High street stores con customers by offering "discounts" which offer little to no savings - and may end up costing more, Which? has claimed.
Britain has claimed victory over Germany in a special football match marking 100 years since the near-legendary WWI Christmas truce match.